Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) CFO Andrew Dickinson sold 3,000 shares of Gilead Sciences stock in a transaction on Monday, December 15th. The stock was sold at an average price of $122.00, for a total transaction of $366,000.00. Following the completion of the transaction, the chief financial officer directly owned 153,503 shares […]

WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) Director Adrian Rawcliffe sold 42,000 shares of the firm’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $15.00, for a total value of $630,000.00. Following the completion of the sale, the director owned 12,700 shares in the […]

WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) Director Gregory Verdine sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $13.47, for a total transaction of $269,400.00. Following the completion of the sale, the director owned 275,217 shares […]

WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) Director Gregory Verdine sold 20,000 shares of the firm’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $13.47, for a total transaction of $269,400.00. Following the sale, the director owned 275,217 shares of the company’s stock, valued […]

WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) insider Chris Francis sold 441,031 shares of the company’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $14.57, for a total transaction of $6,425,821.67. Following the completion of the transaction, the insider owned 25,000 shares of the […]

WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) CFO Kyle Moran sold 50,036 shares of the firm’s stock in a transaction that occurred on Tuesday, December 9th. The shares were sold at an average price of $20.03, for a total transaction of $1,002,221.08. Following the completion of the transaction, the chief financial officer owned […]

WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) Director Heidi Wagner sold 14,000 shares of the stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $13.50, for a total transaction of $189,000.00. Following the completion of the sale, the director directly owned 44,930 shares […]